Gregory Bowyer

Gregory Bowyer has extensive experience in commercial strategy, marketing, and corporate development, with a focus on real-world data and participant health research at Evidation from March 2020 to February 2024. Prior to this, Gregory held senior roles at Accenture from September 2010 to September 2019, where responsibilities included leading the growth of the Life Sciences R&D and Scientific Informatics Services practice and managing consulting projects aimed at improving operational efficiency in clinical and drug safety organizations. Early career experience includes a role as a Reproductive Toxicology Bench Scientist at GSK, supporting pre-clinical studies. Gregory holds a Bachelor of Science degree in Biology from Penn State University.